Official Title
The Effect of Aromatherapy on COVID-19-induced Anxiety
Brief Summary

The purpose of this study is to assess the potential for a non-invasive sensory based intervention to reduce the stress associated with a COVID-19 diagnosis.

Detailed Description

After being informed about the study, participants who provide consent will be randomized to
one of two groups. Participants will receive one of two aromas to inhale with one being
active and the other a control comparison.

Unknown status
Stress
COVID19
Anxiety

Other: Essential Oil Blend

5 drops of on a tester strip

Other: Control Blend

5 drops on a tester strip

Eligibility Criteria

Inclusion Criteria:

- Otherwise healthy

- Documented COVID-19 exposure, suspected infection, or diagnosed infection

- Has been tested for or diagnosed with COVID-19

- adults age 18-65 living in the US

- understands and agrees to comply with study procedures

- provides informed consent

Exclusion Criteria:

- Smoker in household

- Pregnant or may become pregnant

- Difficulty breathing

- Pain or pressure in the chest

- Confusion

- Hospitalization

- Asthma, COPD, or other respiratory condition

- demonstrated inability to comply with study procedures

- has participated in an interventional clinical study within 31 days prior to
enrollment

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 65 Years
Countries
United States
Locations

Franklin Health Research Center
Franklin, Tennessee, United States

Investigator: Jessie Hawkins, PhD
Contact: 615-642-1919
j.hawkins@franklinhealth.org

Contacts

Jessie Hawkins, PhD, Principal Investigator
Franklin Health Research

Franklin Health Research
NCT Number
Keywords
aromatherapy
essential oils
environmental health
MeSH Terms
COVID-19
Anxiety Disorders